Stephen J.LurieMD, PhD, Senior EditorIndividualAuthor
To the Editor: Dr Olfson and colleagues1 report a 3-fold increase in population-wide treatment
of depression in the United States between 1987 and 1997. The authors present
some possible reasons for this increase in their conclusions, specifically
the introduction of selective serotonin reuptake inhibitors (SSRIs), aggressive
pharmaceutical industry advertising, public health educational efforts, and
better available screening instruments.
Rifkin W. Changes in the Treatment of Depression in the United States: 1987-1997. JAMA. 2002;287(14):1803-1804. doi:10.1001/jama.287.14.1799